Research Article
Diabetic Nephropathy Amelioration by a Low-Dose Sitagliptin in an Animal Model of Type 2 Diabetes (Zucker Diabetic Fatty Rat)
Table 1
Body weight, glycaemic, insulinaemic and lipidic profile in the lean control and diabetic ZDF rats at the initial and final time (6 weeks of vehicle or sitagliptin treatment).
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Values are means ± SEM of rats. aLean control (vehicle) versus obese diabetic (vehicle) rats; bdiabetic SITA-treated versus diabetic untreated rats. One, two, or three letters for , , and , respectively. BW: body weight; HbA1c: glycosylated haemoglobin; HOMA: homeostasis model assessment; SITA: sitagliptin; Total-c: total-cholesterol; TGs: triglycerides; ZDF: Zucker diabetic fatty. |